TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -885.64%-148.28M | ---- | 15.88%18.87M | ---- | -64.66%16.29M | ---- | -80.19%46.09M | ---- | 5.12%232.69M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -44.24%-5.68M | ---- | 24.67%-3.94M | ---- | -16.53%-5.23M | ---- | -182.98%-4.49M | ---- | -37.08%-1.59M |
Attributable subsidiary (profit) loss | ---- | 1,987.09%30.4M | ---- | 97.70%-1.61M | ---- | -17.68%-70.04M | ---- | -45.80%-59.52M | ---- | 21.94%-40.82M |
Impairment and provisions: | ---- | 2,687.54%166.22M | ---- | -93.66%5.96M | ---- | -48.62%94.02M | ---- | 913.92%182.97M | ---- | -67.08%18.05M |
-Impairment of property, plant and equipment (reversal) | ---- | --3.96M | ---- | ---- | ---- | -200.00%-27K | ---- | -18.18%27K | ---- | --33K |
-Impairmen of inventory (reversal) | ---- | -27.71%4.36M | ---- | --6.04M | ---- | ---- | ---- | 344.25%4.68M | ---- | 77.87%1.05M |
-Impairment of trade receivables (reversal) | ---- | -1,509.46%-1.19M | ---- | 97.02%-74K | ---- | -209.66%-2.49M | ---- | --2.27M | ---- | ---- |
-Impairment of goodwill | ---- | --92.69M | ---- | ---- | ---- | -45.15%96.53M | ---- | 1,073.33%176M | ---- | -68.75%15M |
-Other impairments and provisions | ---- | --66.4M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -68.48%1.96M |
Revaluation surplus: | ---- | 98.34%-13K | ---- | -175.09%-784K | ---- | -115.91%-285K | ---- | 95.72%-132K | ---- | -6.52%-3.09M |
-Other fair value changes | ---- | 98.34%-13K | ---- | -175.09%-784K | ---- | -115.91%-285K | ---- | 95.72%-132K | ---- | -6.52%-3.09M |
Asset sale loss (gain): | ---- | 336.98%11.65M | ---- | 16.37%-4.91M | ---- | -473.83%-5.88M | ---- | -108.13%-1.02M | ---- | 99.41%-492K |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---4.12M | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | 338.68%11.65M | ---- | -177.22%-4.88M | ---- | -71.88%-1.76M | ---- | -108.13%-1.02M | ---- | -1,361.54%-492K |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---35K | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | -18.82%111.41M | ---- | -5.39%137.24M | ---- | -8.41%145.07M | ---- | 5.01%158.39M | ---- | 6.30%150.84M |
-Amortization of intangible assets | ---- | -90.97%2.14M | ---- | -41.02%23.74M | ---- | -3.63%40.25M | ---- | -16.78%41.77M | ---- | 7.34%50.19M |
Financial expense | ---- | -58.54%4.23M | ---- | -29.25%10.2M | ---- | -30.32%14.42M | ---- | 5.13%20.69M | ---- | -13.60%19.68M |
Unrealized exchange loss (gain) | ---- | -178.52%-15.06M | ---- | 569.72%19.17M | ---- | -2,451.25%-4.08M | ---- | -102.13%-160K | ---- | -28.47%7.52M |
Special items | ---- | 61.47%-425K | ---- | 83.62%-1.1M | ---- | -222.66%-6.73M | ---- | 17.93%-2.09M | ---- | -585.44%-2.54M |
Operating profit before the change of operating capital | ---- | -13.76%154.45M | ---- | 0.88%179.1M | ---- | -47.89%177.54M | ---- | -10.39%340.73M | ---- | 22.05%380.25M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -12,458.53%-47.09M | ---- | 114.73%381K | ---- | -105.11%-2.59M | ---- | 4,732.02%50.63M | ---- | 89.28%-1.09M |
Accounts receivable (increase)decrease | ---- | 484.13%77.31M | ---- | -111.55%-20.13M | ---- | 257.00%174.23M | ---- | 279.56%48.8M | ---- | -110.71%-27.18M |
Accounts payable increase (decrease) | ---- | -519.54%-19.24M | ---- | -93.40%4.59M | ---- | 413.55%69.47M | ---- | -455.29%-22.16M | ---- | 110.97%6.24M |
Special items for working capital changes | ---- | -119.82%-19.22M | ---- | 447.45%96.98M | ---- | -142.98%-27.91M | ---- | 868.90%64.94M | ---- | 92.65%-8.45M |
Cash from business operations | ---- | -43.96%146.21M | ---- | -33.22%260.92M | ---- | -19.09%390.74M | ---- | 38.08%482.94M | ---- | -8.77%349.76M |
Other taxs | ---- | -3.66%-11.74M | ---- | 21.79%-11.32M | ---- | 82.25%-14.48M | ---- | -63.41%-81.58M | ---- | -14.73%-49.92M |
Interest paid - operating | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2.45%-20.31M | ---- | 18.83%-19.82M |
Special items of business | -19.37%79.47M | ---- | -46.13%98.56M | ---- | 3.54%182.97M | ---- | 30.39%176.71M | ---- | 166.32%135.52M | ---- |
Net cash from operations | -19.37%79.47M | -46.12%134.48M | -46.13%98.56M | -33.66%249.6M | 3.54%182.97M | -1.26%376.26M | 30.39%176.71M | 36.08%381.06M | 166.32%135.52M | -11.23%280.02M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 85.24%3.66M | 44.24%5.68M | 144.80%1.98M | -24.67%3.94M | -62.73%808K | 16.53%5.23M | 78.00%2.17M | 182.98%4.49M | 155.88%1.22M | 37.08%1.59M |
Dividend received - investment | ---- | -55.52%36.88M | ---- | 13.59%82.91M | ---- | 31.36%72.99M | 31.36%72.99M | -20.12%55.57M | -20.12%55.57M | -5.79%69.57M |
Decrease in deposits (increase) | ---- | ---- | ---- | -2,951.60%-96.44M | -256.37%-18.78M | 181.20%3.38M | 327.98%12.01M | -362.11%-4.17M | 434.84%2.81M | 125.19%1.59M |
Sale of fixed assets | 18.13%12.07M | 151.35%22.12M | 302.36%10.22M | -82.28%8.8M | -61.04%2.54M | 24.35%49.64M | 570.09%6.52M | 216.13%39.92M | 80.52%973K | 50.85%12.63M |
Purchase of fixed assets | 31.03%-25.09M | -11.00%-75.17M | -12.02%-36.37M | 52.56%-67.72M | 38.73%-32.47M | 24.34%-142.75M | 25.52%-52.99M | -35.92%-188.68M | -30.53%-71.15M | 25.70%-138.81M |
Selling intangible assets | ---- | ---- | ---- | --5.98M | --4.14M | ---- | ---- | ---- | ---- | ---- |
Purchase of intangible assets | ---- | ---387K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of subsidiaries | -11.72%13.71M | ---- | --15.53M | ---- | ---- | --4.12M | ---- | ---- | ---- | -92.49%22.16M |
Acquisition of subsidiaries | ---- | ---- | ---- | ---233.27M | ---233.27M | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | ---- | -96.45%8.1M | -95.99%8.25M | 309.65%228.21M | 727.28%205.81M | -52.64%55.71M | -67.49%24.88M | -88.50%117.64M | -81.78%76.52M | 4.77%1.02B |
Cash on investment | ---- | 110.97%25.24M | 97.41%-5.62M | -315.21%-230.13M | -776.03%-217.16M | 52.55%-55.42M | 67.55%-24.79M | 88.56%-116.82M | 81.78%-76.4M | -2.78%-1.02B |
Other items in the investment business | ---- | ---- | ---- | --8.11M | --8.42M | ---- | ---- | 406.88%1.34M | ---- | -707.41%-436K |
Net cash from investment operations | 172.68%4.36M | 107.75%22.45M | 97.86%-6M | -3,979.01%-289.61M | -786.42%-279.96M | 92.17%-7.1M | 489.65%40.79M | -197.26%-90.71M | -124.03%-10.47M | -231.23%-30.51M |
Net cash before financing | -9.43%83.83M | 492.19%156.93M | 195.43%92.56M | -110.84%-40.01M | -144.59%-96.99M | 27.14%369.16M | 73.92%217.49M | 16.37%290.36M | 32.42%125.06M | -26.33%249.51M |
Cash flow from financing activities | ||||||||||
New borrowing | 23.44%166.36M | -57.55%154.37M | -63.99%134.77M | -24.66%363.67M | 48.37%374.22M | -25.05%482.69M | -55.40%252.22M | 54.98%644.02M | 165.21%565.55M | -20.76%415.55M |
Refund | 51.66%-86.41M | 52.16%-198.96M | 41.68%-178.74M | 25.93%-415.91M | 17.69%-306.47M | -8.19%-561.55M | -141.93%-372.32M | 33.25%-519.03M | 52.40%-153.9M | -35.38%-777.6M |
Interest paid - financing | ---- | 59.23%-4.23M | ---- | 29.95%-10.37M | ---- | ---14.81M | ---- | ---- | ---- | ---- |
Dividends paid - financing | ---- | ---62.72M | ---- | ---- | ---- | 47.73%-156.79M | ---- | -11,552.53%-299.94M | ---- | 98.85%-2.57M |
Other items of the financing business | ---- | ---4.23M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -143.02%-15.03M |
Net cash from financing operations | 281.65%79.88M | -85.00%-115.83M | -165.06%-43.97M | 75.10%-62.61M | 155.88%67.59M | -40.63%-251.43M | -129.55%-120.94M | 53.42%-178.79M | 430.95%409.35M | -37.11%-383.81M |
Effect of rate | 64.82%-7.91M | 64.82%-8.6M | -43.09%-22.49M | -438.09%-24.43M | -145.13%-15.72M | 34.36%7.23M | 3.67%-6.41M | 287.29%5.38M | -1,165.59%-6.66M | 81.68%-2.87M |
Net Cash | 236.97%163.71M | 140.05%41.1M | 265.24%48.58M | -187.17%-102.62M | -130.45%-29.4M | 5.52%117.73M | -81.93%96.55M | 183.08%111.57M | 1,926.90%534.41M | -328.50%-134.3M |
Begining period cash | 10.38%345.8M | -28.85%313.29M | -28.85%313.29M | 39.62%440.35M | 39.62%440.35M | 58.94%315.39M | 58.94%315.39M | -40.87%198.44M | -40.87%198.44M | 14.73%335.61M |
Cash at the end | 47.80%501.59M | 10.38%345.8M | -14.13%339.38M | -28.85%313.29M | -2.54%395.23M | 39.62%440.35M | -44.16%405.53M | 58.94%315.39M | 137.45%726.19M | -40.87%198.44M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.